Astrazeneca AZN
NYSE AZN
$157.68 -3.79 (-2.35%)
As of: Oct 1, 2026 · 3:59 PM EDT

Astrazeneca (AZN) Other financing activities (2009 - 2025)

Updated

Astrazeneca (AZN) recorded Other financing activities of -$169 million in Q4 2025.

Analysis

Astrazeneca (AZN) Other financing activities (2009 - 2025) Analysis & Trends

For FY2025, Astrazeneca reported Other financing activities of -$183 million.

  • Across earlier years, Other financing activities came in at -$149 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Bristol Myers Squibb 127.55 Bn 78.82 Bn 9.25 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -169.00 Mn
Sep 30, 2025 -12.00 Mn
Jun 30, 2009 -1.00 Mn
Mar 31, 2009 -9.00 Mn
API Access

Astrazeneca Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=AZN&period=max&api_key=YOUR_API_KEY